ENDOTEXT: Instructions for Authors

Thank you for participating in Endotext, an online resource providing information for physicians caring for Endocrine patients around the world. Our 450 authors are the very best clinician/teacher/researchers in the world, and our website is the “NY Times” of Endocrine websites.  Endotext is also the only Endocrine textbook indexed in PubMed. With your help, we will maintain these high standards.




Endotext is produced by the non-profit owning company, MDText Inc. Our company is based in Oregon and is a non-profit corporation directed by the section editors and authors. MDText Inc. is run by Ashley Grossman, MD (President), George Chrousos, MD (Vice-President), Jon Purnell, MD (Treasurer) and Sanjay Kalra, MD (Secretary).  The editor of Endotext is Kenneth Feingold. In case you are a new member of the Endotext team, All Section Editors are Directors and all Authors are Members of our non-profit corporation. The control of our company is the same as with any other corporation, with Directors electing officers at our annual meeting, and they in turn run the company on a day to day basis.

Our web textbook is directed to practicing physicians and trainees. This audience includes not only Endocrinologists but also a larger body of physicians seeing Endocrine patients who need ready access to well formulated and clear information on these diseases. Thus, we want to emphasize clinical material, especially disease course, diagnosis, and the latest information on therapy. Enough background on biochemistry, physiology, and pathophysiology should be included for completeness. To set the “level” is difficult. We are not preparing a primer, but rather a text directed to practicing endocrinologists and fellows, as well as general physicians and students. We should provide the same kind of clinically oriented material found in a multi-volume specialty text. We currently are, and intend to be, the equal to (or better than) any currently published hard-cover endocrine text. Perhaps we may visualize something quite distinct – in depth coverage of clinical endocrinology in a single site. We will not print, thus saving an enormous expense and we are able to put material on line and do revisions almost instantaneously.



  • Use doc or Word.docx
  • Use Arial font throughout
  • Paragraph settings (see below)


  • Authors and degrees (BOLD, 12 point) All new authors must register as ENDOTEXT users in order to be listed as authors (registration is free).
  • Affiliations (Please give appropriate titles and affiliations, and e-mail addresses for all authors) 10 point



Jay M. Stewart, M.D., Professor, Department of Ophthalmology, University of California San Francisco, San Francisco, CA 94143. jay.stewart@ucsf.edu

Marco Coassin, M.D., Ph.D., Associate Professor, Department of Ophthalmology, University Campus Bio-Medico, Rome, Italy. m.coassin@unicampus.it

Daniel M. Schwartz, M.D., Professor, Department of Ophthalmology, University of California San Francisco, San Francisco, CA. Dan.Schwartz@ucsf.edu


  • An Abstract suitable for indexing on PubMed should be included. 11 point

Word limit 500


  • Sub-section Headings (H3) (Bold, Capitalize Each Word, 11point, Green) (Heading 3)
  • Sub-Sub Section HEADINGS (H4) (CAPITALIZE WORDS,11pt, Red) (Heading 4)
  • Sub-sub-sub section headings (H5) Italicize, 11point, Orange (Heading 5)
  • Using the above colors will ensure that we correctly indicate your headings during formatting





Cholesterol and Triglycerides


Apolipoprotein B




  • Separate paragraphs by a space. Do not indent.
  • Insert reference numbers into the text in parentheses (1, 2) and list references at the end of the chapter numerically in order of appearance. Use any number of references you wish. The style for references is that used in JCEM.
  • We encourage you to cite other Endotext chapters whenever appropriate. Endotext chapters are indexed on PubMed so they are easy to reference using reference managing systems such as EndNote, and this will increase the visibility of our website.
  • If appropriate you can state “additional information can be found in the chapter entitled “_____” in the ____ section of Endotext (reference #). Do not use chapter numbers as this can change as we add and subtract chapters
  • Most importantly, please use sections to divide chapters as it makes it easier for readers to rapidly find information
  • Line Spacing- this should be 1.15. There should be a space between all new paragraphs


Tables and Figures

  • We would recommend very liberal use of Tables and Figures since these can provide quick and effective information for practicing physicians who may not have time to read a large text.
  • Please insert tables and figures directly in the text where you want them to appear. We recommend having an average of one table or figure for each 2-3,000 words.
  • Create Tables using the MS Word table function.  Please list the Table title in the Table in bold type. (see example below)
  • Use of colored figures is strongly encouraged! Please insert figures directly in the text, and use “JPEG”, GIF, or PNG format. Please do not include the figure title, number, or legend within the figure. Figure legends should be below the figure and in bold
  • As usual, we will need written permission to re-use any figure published elsewhere. Since many journals charge for permission to re-use a figure, and we are unable to provide support for this expense, it is often preferable to modify an illustration so that it is not the same as the original, or to produce a new figure.

Table 1. Etiology of Cushing's Syndrome


Pituitary-dependent Cushing's syndrome (Cushing's disease)

Ectopic ACTH syndrome

Ectopic CRH syndrome (very rare)

Exogenous ACTH administration


Adrenal adenoma

Adrenal carcinoma

ACTH-independent bilateral macronodular adrenal hyperplasia (AIMAH) – now known as bilateral macronodular hyperplasia (BMAH)

AIMAH secondary to abnormal hormone receptor expression/function

Primary pigmented nodular adrenocortical disease (PPNAD), associated with Carney complex or sporadic

McCune-Albright syndrome

Exogenous glucocorticoid administration


  • In an effort to convey the chronic nature of many of the diseases referred to in this textbook, where applicable, please refer to patients “with acromegaly,” “with diabetes,” “with hypertension,” or “who are obese,” rather than “acromegalics”, “diabetics,” “hypertensives,” or “obese patients.”
  • DOSAGES AND SPECIFIC TREATMENTS - Please check all references to dosages and specific treatments very carefully.
  • COPYRIGHT The copyright is owned by MDText.com, INC. For newly written chapters, the authors will transfer copyright to the chapters to MDText.com, INC.
  • Please be sure to add your Endotext publication to your own CV, and to cite it in your lectures and publications. As noted, chapters are indexed on PubMed and therefore are very easy to cite.

For further information or problems, please contact

Kenneth Feingold MD, at kenneth.feingold@ucsf.edu  or 415-302-8463.